Services

Landscape Assessments

Pharma BP develops localised market landscapes including insights on the regulatory environment, pricing and access rules and implications, competitive landscapes and patient journey

Landscape Assessments

Navigating local markets

Therapeutic, regulatory, pricing, and access landscapes are constantly evolving in the MEA region. For any product, at any stage of the clinical life cycle, it is imperative to understand the local market and competitive landscape to understand how to drive sales and support patients.

What sets us apart

Our approach involves a holistic assessment of both the therapeutic category alongside the commercial landscape

  • We assess each local market through a literature review and collect local data on epidemiology, unmet needs, competitive, regulatory, pricing, and access landscapes
  • We ensure that local data and insights are validated through a robust qualitative research programme. Primary insights are also leveraged to fill local data gaps given the scarcity of data in the MEA region
  • We forecast how the local access environment will evolve over a 3-5 year period and impact regulatory timelines, product pricing, reimbursement and access as policies evolve and competitors enter the market